MicroClinic Technologies Chairperson Mary Matu said that the money will be used to improve the health of children especially under the age of five years/COURTESY
The system is designed to tackle the quality of maternal and child healthcare by facilitating diagnosis and treatment of common diseases that affect women and children.
MicroClinic Technologies Chairperson Mary Matu said that the money will be used to improve the health of children especially under the age of five years.
“We are thrilled to be recipients of the GSK and Save the Children Healthcare Innovation Award. The award money will fast track the start of a national roll-out, and will soon impact the lives of over 40,000 under-fives who will receive services in the model ZiDi™ sub-counties of Ruiru and Gatundu in Kiambu County, starting December 2013. With ZiDi™ national rollout, more lives will be saved as a result of access to reliable medical supplies and improved diagnosis,” she said.
The system is able to monitor service utilisation and consumption of vaccines and all essential drugs and accurately forecast the potential demand for over 5,000 health facilities in Kenya.
It was one of five projects, from a long list of nearly 100 applications from 29 countries from across the developing world, selected by the judging panel.
The award is the first initiative delivered as part of ambitious partnership between GSK and Save the Children that aims to save a million children’s lives.
MicroClinic Technologies Ltd. was awarded Sh8.64 million by the partnership to further develop the system for larger health facilities.
About The Author
